| Literature DB >> 2965002 |
P A Arnold1, B J Guglielmo, H Hollander.
Abstract
A patient with acquired immunodeficiency syndrome (AIDS) developed rash, fever, neutropenia, and elevated liver function tests during an initial course of trimethoprim-sulfamethoxazole (TMP-SMX) therapy. Upon reexposure to the drug, the patient experienced a severe anaphylactoid reaction associated with pulmonary edema and rhabdomyolysis. Reactions associated with TMP-SMX rechallenge in this patient population have been previously reported but have not been associated with this degree of severity. TMP-SMX therapy should be instituted with extreme caution in patients with AIDS who have demonstrated a prior hypersensitivity reaction to the drug.Entities:
Mesh:
Substances:
Year: 1988 PMID: 2965002 DOI: 10.1177/106002808802200110
Source DB: PubMed Journal: Drug Intell Clin Pharm ISSN: 0012-6578